European Society of Hyperthermic
Oncology
Whole body hyperthermia:
Systemic multimodal cancer therapy (42°C) combined with 5-FU and Mitomycin in metastatic colorectal carcinoma
Coordination:
Prof. Dr. med. H. Riess
Dr. med. B. Hildebrandt
Medizinische Klinik
Prof. Dr. med. P. Wust
Klinik für Strahlenheilkunde
Charité - Campus Virchow-Klinikum
13353 Berlin
Tel: -49-30-450-53013 or 57023/57202
Whole body hyperthermia:
Open, randomized, multicentric phase III trail of Oxaliplatin and 5-Fluorouracil/Leucovorin as second and third line therapy in locally advanced or metas-tatic, nonresectable colorectal carcinoma and documented progression within three months after high dose therapy with 5-Fluorouracil (25h)/Leucovorin (ARDALAN) or CPT-11 containing protocols.
Coordination:
Prof. Dr. med. S. Hegewisch-Becker
Abt. für Onkologie und Hämatologie
Universitätsklinik Eppendorf
Hamburg
Tel: +49-40-42803-3971
Regional Hyperthermia:
Prospective phase I/II study of regional hyperthermia and radiotherapy of hepatic metastases in colorectal carcinoma.
Coordination:
Prof. Dr. med. M. Bamberg
Dr. med. T. Hehr
Abteilung für Strahlentherapie
Universitätsklinikum Tübingen
Tel: +49-7071-29-82166